Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
111.00    0.00 (0.00%)
Bid:
110.00
Ask:
112.00
Spread: 2.00 (1.818%)
Market Cap: £14.97m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Directorate Change

30 Dec 2016 09:22

RNS Number : 0466T
Revolymer PLC
30 December 2016
 

30 December, 2016

Revolymer plc

Directorate Change

 

Revolymer plc ("Revolymer" or the "Company"), announces that two of its non executive directors, Mr John "Jack" Keenan and Mr Robert Frost, are retiring from the board with effect from 31 December 2016.

Mr Keenan has been a non executive director of the business since January 2008, and was Chairman from the flotation on the AIM Market in July 2012 to September 2015. He has played a significant role throughout this period, applying his considerable experience to guiding the commercial development of the business as well providing advice on corporate governance.

Mr Frost joined the board at its flotation on the AIM Market in July 2012 as the nominated director of Naxos Capital Partners ("Naxos"), an investor in the business since May 2010. As well as representing the interests of Naxos, he has made a considerable contribution to the development of the business born out of his commercial experience in the chemicals industry and his investing expertise.

Kevin Matthews, Revolymer CEO, said "We would like to thank both Jack and Robert for their valuable advice and guidance to Revolymer over a number of years, and wish them the very best for the future. We are delighted that Naxos remains a supportive long term shareholder in the business"

Ends

For further information please contact:

Revolymer plc

+44 (0) 1244 283 500

Kevin Matthews / Rob Cridland

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Adam James (Corporate Finance)

Charles Leigh-Pemberton (Corporate Broking)

About Revolymer

 

Revolymer is an AIM quoted company (registered number 08024489) whose aim is to be a leader in functional polymers that improve the safety, performance or sustainability of our customer's products in the delivery and controlled release of actives, surface modification, and water quality improvement for the Homecare & Industrial and Personal Care & Consumer Healthcare markets.

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAURUKRNAAUORA
Date   Source Headline
10th Jun 20262:43 pmRNSResult of AGM
2nd Jun 20267:00 amRNSMello 2026 Presentation and Update on Trading
1st Jun 20267:00 amRNS-RProgress in Crop Production Field Trials
29th May 20267:00 amRNS-RDevelopment of Next Generation Plant-Based Paints
27th May 20267:00 amRNS-RLaunch of New Marketing Program for Detergents
14th May 20265:55 pmRNSAdjournment of AGM
6th May 20264:46 pmRNSDirector/PDMR Shareholding
27th Apr 20266:16 pmRNSTR-1
23rd Apr 20267:00 amRNSGrants of Options & PDMR dealings
24th Mar 20267:00 amRNSPreliminary Results
28th Jan 20267:00 amRNSTR-1
16th Jan 20265:29 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFull Year Trading Update
15th Sep 20257:00 amRNSHalf Year Results
4th Sep 20257:00 amRNSNotice of Interim Results
27th Aug 20258:19 amRNSTR-1
23rd Jul 20257:00 amRNSH1 2025 Trading Update
16th Jul 20257:00 amRNS-RCroda expands agreement: sustainable odour control
1st Jul 20257:00 amRNS-RCommercial Plant-Based Product Launch
8th May 20252:20 pmRNSResult of AGM
6th May 202512:24 pmRNSTR-1
2nd May 20255:28 pmRNSNotice of AGM
1st May 20257:00 amRNSUpdate on US Tariffs
7th Apr 20257:00 amRNSGrants of Options & PDMR dealings
31st Mar 20257:00 amRNSPreliminary Results
18th Mar 20257:00 amRNSNotice of Results and Company Presentation
22nd Jan 20257:00 amRNSTrading Update
5th Nov 20247:00 amRNSTrading Update
10th Oct 20247:00 amRNSChange of Auditor
10th Sep 20247:00 amRNSHalf Year Results
2nd Sep 20247:00 amRNSNotice of Interim Results, Investor Presentation
16th Jul 20247:00 amRNSH1 2024 Trading Update
20th May 20243:03 pmRNSResult of AGM
20th May 20247:00 amRNSAGM Statement and Trading Update
29th Apr 20247:00 amRNSLaunch of two plant-based performance ingredients
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.